In the Pipeline: Gene Therapy - Pfizer Inc.
Three Gene Therapy Study Updates for Duchenne Muscular Dystrophy
The CIFFREO Study - Community
The CIFFREO Study – Clinician
Gene Therapy Approaches to Replace or Restore Dystrophin -- PPMD 2022 Annual Conference
Duchenne Muscular Dystrophy: Could Gene Therapy Be the Answer? Exploring SRP-9001
[Webinar] Domagrozumab as a Potential Treatment for Duchenne - May 2019
Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (October 2021)
Webinar: Resiliency in Results – What We Learn When Trials Are Terminated (September 2020)
Gene Therapy for DMD How it Works and the Ongoing Clinical Trials
DMD and Gene Therapy What's On the Horizon
PPMD 2019 Conference - Gene Therapy Trials
043 - Sarepta keeps the gene therapy throne in DMD! ContraVir submits NASH IND!
Dr. Jacinda Sampson - DMD Research: What's Next?
In the Pipeline: Gene Therapy - Day 3 - PPMD Annual 2020
CureDuchenne and REGENXBIO Webinar: RGX-202 - REGENXBIO’s investigational gene therapy for DMD
The basics of genetic approaches for NMDs – using DMD as a paradigm - Annemieke Aartsma-Rus
PPMD 2019 Conference - Gene Correction
Vision-DMD Update on Vamolorone
DMD by Pfizer Sep 29 2021